Gemfibrozil: all 28 studies that test it
Page 1 of 1. Open to participants first (1), then studies with results posted, then the rest; newest registration first within each.
- Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of PLX-200 in Pediatric Patients (Master Protocol)Not yet recruitingNCT07740512Phase 2
- Evaluation of the Potential Drug-drug Interactions Between Gemfibrozil or Dabigatran Etexilate and CamlipixantCompletedNCT05959447Phase 1Results posted
- Exploration of Gemfibrozil as a Treatment for AUDTerminatedNCT03539432Phase 2Results posted
- Gemfibrozil for Nicotine Smoking CessationCompletedNCT02638597Phase 2Results posted
- Initial Screening of Gemfibrozil as a Novel Treatment for Tobacco AddictionCompletedNCT01876810Phase 2Results posted
- The Effect of Gemfibrozil, Ketoconazole and Clarithromycin on the Amount of LY2409021 in the BloodstreamCompletedNCT01836198Phase 1Results posted
- A Study of Evacetrapib in Healthy ParticipantsCompletedNCT01736254Phase 1Results posted
- A Study Investigating the Effect of Different Approved Medications on How the Body Processes the Study Compound RO7795081CompletedNCT06809608Phase 1
- A Phase 1, Open-label Study Evaluating the Pharmacokinetics and Drug-drug Interaction of VX-993 in Healthy AdultsCompletedNCT06392659Phase 1
- Study of Drug-drug Interaction of the Effects of Gemfibrozil and Rifampicin on SAR442168 in Healthy Adult SubjectsCompletedNCT06064539Phase 1
- A Study to Assess the Effect of Multiple Doses of Itraconazole, Gemfibrozil, or Carbamazepine on BMS-986278 in Healthy ParticipantsCompletedNCT05932303Phase 1
- Study to Evaluate the Safety, Tolerability, Efficacy, and PK of FHL-301 in Parkinson's Disease Patients.WithdrawnNCT05931484Phase 2
- A Study to Investigate the Drug-drug Interactions (DDIs) of SKLB1028 With Itraconazole, Gemfibrozil or Rifampicin in Healthy SubjectsStatus unknownNCT05069870Phase 1
- A Study to Assess the Effect of Itraconazole, Phenytoin and Gemfibrozil on the Drug Levels of BMS-986166 in Healthy ParticipantsCompletedNCT04956627Phase 1
- Safety, Tolerability, and Efficacy of PLX-200 in Patients With CLN3WithdrawnNCT04637282Phase 3
- A Clinical Study to Investigate the Effect of Gemfibrozil or Rifampicin on Blood Concentrations of Selexipag in Healthy SubjectsCompletedNCT02770222Phase 1
- Study to Assess Drug-Drug Interaction Between Itraconazole or Gemfibrozil and JNJ-56021927CompletedNCT02230033Phase 1
- Modulation of Micro-RNA Pathways by Gemfibrozil in Predementia Alzheimer DiseaseCompletedNCT02045056Early Phase 1
- Drug-drug Interaction Study With MDV3100 (ASP9785) and Gemfibrozil and ItraconazoleCompletedNCT01913379Phase 1
- A Study to Assess the Effect of Multiple Doses of Gemfribozil on a Single Dose of ASP3652, and to Assess the Effects of Multiple Doses of ASP3652 on a Single Dose of Repaglinide in the Body of Healthy SubjectsCompletedNCT01797198Phase 1
- Study to Assess the Pharmacokinetics of GSK1278863A Coadministered With a High Fat Meal or an Inhibitor of CYP2C8 (Gemfibrozil)CompletedNCT01376232Phase 1
- A Pharmacokinetics Study of the Effects of GSK2118436 on Warfarin, the Effects of Ketoconazole and Gemfibrozil on GSK2118436, and the Effects of Repeat Doses of GSK2118436 in Subjects With BRAF Mutant Solid TumorsCompletedNCT01340846Phase 1
- To Evaluate the Effect of Gemfibrozil on the Pharmacokinetics and Pharmacodynamics of a Single Dose of AZD1656CompletedNCT01083212Phase 1
- Study Evaluating Potential Interaction Between SAM-531 And Gemfibrozil When Co-AdministeredCompletedNCT00966966Phase 1
- Bioequivalence Study Between Two Oral Formulations of Gemfibrozil TabletsCompletedNCT00800475Phase 1
- Drug-Drug Interaction Study of Mitiglinide and GemfibrozilCompletedNCT00566865Phase 1
- The VA HDL Intervention Trial (HIT): Secondary Prevention of Coronary Heart Disease in Men With Low HDL-Cholesterol and Desirable LDL-CholesterolCompletedNCT00283335Phase 3
- Effect of Gemfibrozil on Serum Glycosylphosphatidylinositol (GPI) Phospholipase D and TriglyceridesCompletedNCT00108511Phase 1